SavedAdd your journal

Journals / Journal of Clinical and Experimental Investigations / 2013 / Cilt: 4 - Sayı: 2

Frequency of HBsAg, anti-HCV, and anti-HIV in pregnant women and/or patients with gynecologic diseases in a tertiary hospital

Üçüncü basamak bir hastanedeki gebe ve/veya jinekolojik hastalıklı kadınlarda HBsAg, anti-HCV ve anti-HIV sıklığı

Esra KOÇOĞLU
Tekin TAŞ
Melahat Emine DÖNMEZ
Tülay ÖZLÜ
Fırat Zafer MENGELOĞLU
Pages
166–170
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since there is no effective method of prevention especially from HCV, awareness of this serologic result before high risk procedures will enable the doctors and the health care workers to take extensive measures to prevent the transmission of the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are viruses that can be transmitted to the health care workers by infected body fluids and from mother to the baby before, during or after delivery.
📊
Key Findings & Data:Methods: HBsAg, anti-HCV, and anti-HIV results of the pregnant women and/or patients with gynecologic diseas- es that admitted to the obstetrics and gynecology clinics between January 2006 and June 2012 were retrospectively investigated.
💡
Conclusion & Impact:Since there is no effective method of prevention especially from HCV, awareness of this serologic result before high risk procedures will enable the doctors and the health care workers to take extensive measures to prevent the transmission of the disease.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are viruses that can be transmitted to the health care workers by infected body fluids and from mother to the baby before, during or after delivery. In the present study, we aimed to investigate the frequency of hepatitis B surface antigens (HBsAg), hepatitis C antibodies (anti-HCV), and HIV antibodies (anti-HIV) in pregnant women and/or patients with gynecologic diseases that admit to a university hospital in Bolu. Methods: HBsAg, anti-HCV, and anti-HIV results of the pregnant women and/or patients with gynecologic diseas- es that admitted to the obstetrics and gynecology clinics between January 2006 and June 2012 were retrospectively investigated. All markers were tested in the microbiology laboratory of our hospital by using macro ELISA method (Axsyme and Architect i2000SR systems, Abbott Diagnostics, Chicago, IL, USA). Results: The frequency of HBsAg, anti-HCV, and anti- HIV positivity were 1.8%, 0.5%, and 0% in pregnant women and 1.9%, 1.1%, and 0% in patients with gynecologic diseases, respectively. Conclusion: The frequencies detected in our hospital are at low levels as seen in developed countries. Since there is no effective method of prevention especially from HCV, awareness of this serologic result before high risk procedures will enable the doctors and the health care workers to take extensive measures to prevent the transmission of the disease.

Özet

Amaç: Hepatit B virüsü (HBV), Hepatit C virüsü (HCV)ve insan immün yetmezlik virüsü (HIV) enfekte vücut sıvılarıyla sağlık çalışanlarına ve enfekte anneden bebeğe bulaşabilen virüslerdir. Çalışmamızda Bolu ilinde birüniversite hastanesine başvuran gebe ve/veya jinekolojik hastalıklı kadınlarda; hepatit B yüzey antijenleri (HBsAg), hepatit C antikorları (anti-HCV) ve HIV antikorlarının (an- ti-HIV) sıklığını belirlemeyi amaçladık.Yöntemler: Ocak 2006-Haziran 2012 tarihleri arasında Kadın Hastalıkları ve Doğum polikliniklerine başvuran gebe ve/veya jinekolojik hastalıklı kadınlara ait HBsAg, anti-HCV ve anti-HIV sonuçları retrospektif olarak tarandı. Tüm belirteçler hastanemiz mikrobiyoloji laboratuvarında makro ELISA yöntemi kullanılarak (Axsyme ve Architect i2000SR sistemleri, Abbott Diagnostics, Chicago, IL, ABD) çalışıldı. Bulgular: HBsAg, anti-HCV ve anti-HIV pozitifliği gebe kadınlarda %1.8, %0.5 ve %0, jinekolojik hastalıklı kadınlarda ise bu oranlar %1.9, %1.1 ve %0 olarak saptandı. Sonuç: Hastanemizde tespit edilen sıklıklar gelişmiş ülkeler seviyesindedir. Özellikle HCV için sekonder korunma amacıyla uygulanabilecek etkin bir yöntem olmadığından, hastalarda müdahale öncesi HBsAg, anti-HCV ve anti-HIV pozitifliğinin bilinmesi hekim ve diğer sağlık çalışanları tarafından hastalık bulaşını önleyici tedbirlerin alınmasına imkân sağlayacaktır.

🔖

Cite This Article

KOÇOĞLU, E., TAŞ, T., DÖNMEZ, M. E., ÖZLÜ, T., MENGELOĞLU, F. Z. (2022). Frequency of HBsAg, anti-HCV, and anti-HIV in pregnant women and/or patients with gynecologic diseases in a tertiary hospital. Journal of Clinical and Experimental Investigations, Cilt: 4 - Sayı: 2, 166–170. https://ajindex.com/articles/561854

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990;8(Suppl 18-20):21-23
  2. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990;263:1218-1222
  3. Ökten A. [The etiology of chronic hepatitis, cirrhosis and hepatocellular carcinoma in Turkey]. Güncel Gastroenterol 2003;7:187-191
  4. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-5675
  5. Turhan NÖ, Kaygusuz İÇ, Pekel A. [Assisted Reproduction Techniques in HIV Positive Couples: Review]. Turkiye Klinikleri J Gynecol Obst 2007;17:117-125
  6. Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period- are they opportunities for treatment? J Viral Hepat 2011;18:229-236
  7. U.S. Preventive Services Task Force. Screening for hepatitis B virus infection in pregnancy: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2009;150:869
  8. Lin K, Vickery J. Screening for hepatitis B virus infection in pregnant women: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2009;150:874
  9. Workowski KA, Berman S. Centers for Disease Control and Prevention (CDC).Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110
  10. Tekin A, Deveci Ö. [Seroprevalences of HBV, HCV and HIV among healthcare workers in a state hospital.]. Clin Exp Invest 2010;1:99-103
  11. Kuru Ü, Turan Ö, Ceylan Y, et al. [Incidence of HBsAg positivity in pregnancy]. Klimik Derg 1992;5:83-86
  12. Kadanalı A, Çelebi S, Aydos SK, Kadanalı S, Ayyıldız A. [Perinatal Transmission of Hepatit B virus in Erzurum]. AÜTD 1997;29:450-452
  13. Gül A, Türkdoğan MK, Zeteroğlu Ş. [The prevalance of Hepatit B and Hepatit C in a group of pregnant women]. Perinatoloji Dergisi 1998;6:67-69
  14. Biri A, Kılıç G, Bozdayı G, Tezcan S. Prevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Viruses during pregnancy. T Klin J Med Res 2001;19:100-103
  15. Sağsöz N, Apan T. [The rates of tetanus, Hepatitis B and Rubella seropositivity in pregnants]. T Klin J Gy- necol Obst 2002;2:52-55
  16. Karaca Ç, Karaca N, Usta T, et al. [The frequencies of Hepatitis B, C, D virus infection in the pregnant population and the rate of perinatal transmission of Hepatitis C virus]. Akademik Gastroenteroloji Dergisi 2003;